Literature DB >> 21511817

TRPC6 gene variants in Turkish children with steroid-resistant nephrotic syndrome.

Sevgi Mir1, Onder Yavascan, Afig Berdeli, Betul Sozeri.   

Abstract

BACKGROUND: In steroid-resistant nephrotic syndrome (SRNS), a considerable number of patient progress to end-stage renal disease (ESRD), despite aggressive therapy. The latest advance in familial focal segmental glomerulosclerosis (FSGS) has been the discovery of a mutant form of canonical transient receptor potential channel 6 (TRPC6) leading to FSGS through unclear mechanisms. The aim of this study is to screen for TRPC6 mutations in familial and sporadic SRNS patients.
METHODS: Twenty-five children with SRNS originating from Turkey were included in this study. Nine patients had familial and 16 patients had sporadic SRNS. Mutation analysis was performed in all 13 coding exons of the TRPC6 gene with the direct DNA sequencing method. The control group consisted of 50 normal healthy children originating from Turkey.
RESULTS: No mutation was detected in nine children (four familial, five sporadic). A variant (L395A) in one patient, intronic nucleotide substitution (c.171 + 16 A>G and c.171 + 86 G>C) in six patients and previously described missense (A404V; rs36111323) and synonymous (N561N; rs12366144) aminoacid variants in nine patients were found. Among patients with intronic, missense and synonymous aminoacid variants, 5 patients had familial and 11 patients had sporadic SRNS. Their mean age at onset of proteinuria was 2.6 ± 1.7 years. Seven cases (three familial, four sporadic) progressed to ESRD with a mean time of 10.2 ± 2.9 years.
CONCLUSIONS: In conclusion, analysis of TRPC6 gene mutations in FSGS will provide new insights into the pathogenesis of nephrotic syndrome. Previous works have emphasized that the patients with only hereditary familial FSGS carried a missense mutation in the TRPC6 gene. Our findings suggest that TRPC6 mutations may also have an important role in the pathogenesis of sporadic SRNS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21511817     DOI: 10.1093/ndt/gfr202

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  14 in total

Review 1.  Role of TRPC6 in Progression of Diabetic Kidney Disease.

Authors:  Alexander Staruschenko; Denisha Spires; Oleg Palygin
Journal:  Curr Hypertens Rep       Date:  2019-05-21       Impact factor: 5.369

2.  TRPC6 G757D Loss-of-Function Mutation Associates with FSGS.

Authors:  Marc Riehle; Anja K Büscher; Björn-Oliver Gohlke; Mario Kaßmann; Maria Kolatsi-Joannou; Jan H Bräsen; Mato Nagel; Jan U Becker; Paul Winyard; Peter F Hoyer; Robert Preissner; Dietmar Krautwurst; Maik Gollasch; Stefanie Weber; Christian Harteneck
Journal:  J Am Soc Nephrol       Date:  2016-02-18       Impact factor: 10.121

3.  TRPC6 Inactivation Reduces Albuminuria Induced by Protein Overload in Sprague Dawley Rats.

Authors:  Eun Young Kim; Stuart E Dryer
Journal:  Cells       Date:  2022-06-21       Impact factor: 7.666

4.  Dealing with the incidental finding of secondary variants by the example of SRNS patients undergoing targeted next-generation sequencing.

Authors:  Stefanie Weber; Anja K Büscher; Henning Hagmann; Max C Liebau; Christian Heberle; Michael Ludwig; Sabine Rath; Martin Alberer; Antje Beissert; Martin Zenker; Peter F Hoyer; Martin Konrad; Hanns-Georg Klein; Julia Hoefele
Journal:  Pediatr Nephrol       Date:  2015-08-07       Impact factor: 3.714

5.  Characterization of a Trpc6 Transgenic Mouse Associated with Early Onset FSGS.

Authors:  Cesar P Canales; Paola Krall; Pamela Kairath; Irene C Perez; Miryam A Fragoso; Paulina Carmona-Mora; Phillip Ruiz; Jochen Reiser; Juan I Young; Katherina Walz
Journal:  Br J Med Med Res       Date:  2014-10-30

6.  Focal segmental glomerulosclerosis and end-stage kidney disease in children.

Authors:  Alaleh Gheissari
Journal:  J Nephropharmacol       Date:  2015-05-17

7.  TRPC6 gene promoter polymorphisms in steroid resistant nephrotic syndrome children.

Authors:  Kempanahalli Basappa Mahesh Kumar; Senguttuvan Prabha; Elumalai Ramprasad; Lakkakula Vks Bhaskar; Periasamy Soundararajan
Journal:  J Nephropharmacol       Date:  2015-02-23

8.  A novel TRPC6 mutation in a family with podocytopathy and clinical variability.

Authors:  Amy K Mottl; Mei Lu; Catherine A Fine; Karen E Weck
Journal:  BMC Nephrol       Date:  2013-05-10       Impact factor: 2.388

9.  Screening for urinary biomarkers of steroid-resistant nephrotic syndrome in children.

Authors:  Yongqi Bai; Wenjun Liu; Qulian Guo; Yan Zou
Journal:  Exp Ther Med       Date:  2012-12-21       Impact factor: 2.447

10.  AngII-induced glomerular mesangial cell proliferation inhibited by losartan via changes in intracellular calcium ion concentration.

Authors:  Guoying Qiu; Zequan Ji
Journal:  Clin Exp Med       Date:  2013-03-05       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.